Belenus

Ultrasound Sensor Specialist Novosound Inks Deal With Nasdaq-listed PAVmed Inc. to Advance Intravascular Imaging Technology

Retrieved on: 
Wednesday, December 21, 2022
Medical Devices, Health, Technology, Health Technology, Wearables, Mobile Technology, Hardware, BAE Systems, Partnership, GE Aviation, CES, Scottish Enterprise, Multimedia, Traction, DirectSound, Par, Nebula, NDT, Strategic Foresight Group, Aviation, Medical imaging, Kelpie, Belenus

Ultrasound sensor specialist Novosound has signed a commercial partnership agreement with PAVmed Inc. , the Nasdaq-listed diversified medical technology company, to develop technology aimed at advancing intravascular imaging.

Key Points: 
  • Ultrasound sensor specialist Novosound has signed a commercial partnership agreement with PAVmed Inc. , the Nasdaq-listed diversified medical technology company, to develop technology aimed at advancing intravascular imaging.
  • The PAVmed agreement furthers Novosound’s move into healthcare, and its regional expansion into North America.
  • The company has announced a series of international contract wins over the last twelve months, including with aerospace groups BAE Systems and GE Aviation, and Israeli-based digital health company dSound.
  • Novosound will be exhibiting its wireless wearable ultrasound platform at CES 2023 in Las Vegas between 5-8 January.